Orchid Pharma Limited (ORCHPHARMA) — Strategic Asset Allocation Index
Orchid Pharma Limited (ORCHPHARMA) has a Strategic Asset Allocation Index of 99.0% as of September 2022. Strategic assets (PP&E of Rs6.16 Billion plus long-term investments of Rs-) total Rs6.16 Billion, measured against net assets of Rs6.22 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Orchid Pharma Limited Strategic Asset Allocation Index (2020–2022)
This chart shows how Orchid Pharma Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 99.0%, representing strategic assets of Rs6.16 Billion against net assets of Rs6.22 Billion INR. Explore cash efficiency ratio of Orchid Pharma Limited to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Orchid Pharma Limited (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Orchid Pharma Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Orchid Pharma Limited (ORCHPHARMA) total market value.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 91.6% | Rs5.93 Billion | Rs5.93 Billion | Rs- | Rs6.47 Billion | ▼ -12.1 pp |
| 2021 | 103.8% | Rs6.78 Billion | Rs6.78 Billion | Rs- | Rs6.53 Billion | ▼ -8.3 pp |
| 2020 | 112.1% | Rs8.59 Billion | Rs8.59 Billion | Rs- | Rs7.66 Billion | — |